Cargando…
Novel mRNA therapy restores GALT protein and enzyme activity in a zebrafish model of classic galactosemia
Messenger RNA (mRNA) has emerged as a novel therapeutic approach for inborn errors of metabolism. Classic galactosemia (CG) is an inborn error of galactose metabolism caused by a severe deficiency of galactose‐1‐phosphate:uridylyltransferase (GALT) activity leading to neonatal illness and chronic im...
Autores principales: | Delnoy, Britt, Haskovic, Minela, Vanoevelen, Jo, Steinbusch, Laura K. M., Vos, Esther Naomi, Knoops, Kèvin, Zimmermann, Luc J. I., Noga, Marek, Lefeber, Dirk J., Martini, Paolo G. V., Coelho, Ana I., Rubio‐Gozalbo, Maria Estela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541528/ https://www.ncbi.nlm.nih.gov/pubmed/35527402 http://dx.doi.org/10.1002/jimd.12512 |
Ejemplares similares
-
Nucleotide sugar profiles throughout development in wildtype and galt knockout zebrafish
por: Haskovic, Minela, et al.
Publicado: (2020) -
Current and Future Treatments for Classic Galactosemia
por: Delnoy, Britt, et al.
Publicado: (2021) -
Impaired fertility and motor function in a zebrafish model for classic galactosemia
por: Vanoevelen, Jo M., et al.
Publicado: (2017) -
Pathophysiology and targets for treatment in hereditary galactosemia: A systematic review of animal and cellular models
por: Haskovic, Minela, et al.
Publicado: (2020) -
Ovarian function in girls and women with GALT-deficiency galactosemia
por: Fridovich-Keil, Judith L., et al.
Publicado: (2010)